Literature DB >> 28704653

Double the Trouble When Herpesviruses Join Hands.

Un Yung Choi1, Angela Park1, Jae U Jung2.   

Abstract

KSHV is the etiologic agent of PEL-an aggressive lymphoma. Interestingly, EBV concurrently exists in nearly 70% of PEL cases. In this issue of Cell Host & Microbe, McHugh et al. (2017) develop humanized mouse models for EBV/KSHV co-infection and identify their complementary effect on in vivo tumor formation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2017        PMID： 28704653      PMCID： PMC6951242          DOI： 10.1016/j.chom.2017.06.016

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN： 1931-3128            Impact factor:   21.023


  10 in total

1.  Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.

Authors:  Donal McHugh; Nicole Caduff; Mario Henrique M Barros; Patrick C Rämer; Ana Raykova; Anita Murer; Vanessa Landtwing; Isaak Quast; Christine T Styles; Michael Spohn; Adeola Fowotade; Henri-Jacques Delecluse; Alexandra Papoudou-Bai; Yong-Moon Lee; Jin-Man Kim; Jaap Middeldorp; Thomas F Schulz; Ethel Cesarman; Andrea Zbinden; Riccarda Capaul; Robert E White; Martin J Allday; Gerald Niedobitek; David J Blackbourn; Adam Grundhoff; Christian Münz
Journal:  Cell Host Microbe       Date:  2017-07-12       Impact factor: 21.023

2.  An animal model for acute and persistent Epstein-Barr virus infection.

Authors:  A Moghaddam; M Rosenzweig; D Lee-Parritz; B Annis; R P Johnson; F Wang
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

3.  Activation of CD21 and CD23 gene expression by Kaposi's sarcoma-associated herpesvirus RTA.

Authors:  Heesoon Chang; Yousang Gwack; Dior Kingston; John Souvlis; Xiaozhen Liang; Robert E Means; Ethel Cesarman; Lindsey Hutt-Fletcher; Jae U Jung
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas.

Authors:  Shi-Dong Ma; Subramanya Hegde; Ken H Young; Ruth Sullivan; Deepika Rajesh; Ying Zhou; Ewa Jankowska-Gan; William J Burlingham; Xiaoping Sun; Margaret L Gulley; Weihua Tang; Jenny E Gumperz; Shannon C Kenney
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

5.  Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice.

Authors:  C Boshoff; S J Gao; L E Healy; S Matthews; A J Thomas; L Coignet; R A Warnke; J A Strauchen; E Matutes; O W Kamel; P S Moore; R A Weiss; Y Chang
Journal:  Blood       Date:  1998-03-01       Impact factor: 22.113

6.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

7.  KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo.

Authors:  William Wu; Jeffrey Vieira; Nancy Fiore; Prabal Banerjee; Michelle Sieburg; Rosemary Rochford; William Harrington; Gerold Feuer
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

8.  Humanized-BLT mouse model of Kaposi's sarcoma-associated herpesvirus infection.

Authors:  Lin-Xu Wang; Guobin Kang; Pankaj Kumar; Wuxun Lu; Yue Li; You Zhou; Qingsheng Li; Charles Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

9.  Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile.

Authors:  Richard G Jenner; Karine Maillard; Nicola Cattini; Robin A Weiss; Chris Boshoff; Richard Wooster; Paul Kellam
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-18       Impact factor: 11.205

10.  Non-human primate model of Kaposi's sarcoma-associated herpesvirus infection.

Authors:  Heesoon Chang; Lynn M Wachtman; Christine B Pearson; Jong-Soo Lee; Hye-Ra Lee; Steven H Lee; Jeffrey Vieira; Keith G Mansfield; Jae U Jung
Journal:  PLoS Pathog       Date:  2009-10-02       Impact factor: 6.823
  10 in total
  4 in total

1.  Kaposi Sarcoma-Associated Herpesvirus Infection and Endemic Burkitt Lymphoma.

Authors:  Peter O Oluoch; Cliff I Oduor; Catherine S Forconi; John M Ong'echa; Christian Münz; Dirk P Dittmer; Jeffrey A Bailey; Ann M Moormann
Journal:  J Infect Dis       Date:  2020-06-16       Impact factor: 5.226

2.  Epstein-Barr virus reactivation influences clonal evolution in human herpesvirus-8-related lymphoproliferative disorders.

Authors:  Massimo Granai; Mattia Facchetti; Virginia Mancini; Jacqueline Goedhals; Alicia Sherriff; Lucia Mundo; Cristiana Bellan; Teresa Amato; Ester Sorrentino; Marco Ungari; Martine Raphael; Lorenzo Leoncini; Fabio Facchetti; Stefano Lazzi
Journal:  Histopathology       Date:  2021-10-04       Impact factor: 7.778

Review 3.  Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers.

Authors:  Miroslava Šudomová; Kateřina Berchová-Bímová; Stefania Marzocco; Alena Liskova; Peter Kubatka; Sherif T S Hassan
Journal:  Viruses       Date:  2021-05-28       Impact factor: 5.048

Review 4.  Extracellular vesicles: novel vehicles in herpesvirus infection.

Authors:  Lingzhi Liu; Quan Zhou; Yan Xie; Lielian Zuo; Fanxiu Zhu; Jianhong Lu
Journal:  Virol Sin       Date:  2017-10-30       Impact factor: 4.327
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.